Biopharma
Page 1 • 5 itemsGlobal biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.
FDA Breakthrough Therapy TargTex TX202: What You Need to Know
TargTex TX202 is an FDA breakthrough therapy designed to treat advanced melanoma, offering new hope and innovative treatment options for patients.
FDA Approves BriaCell's Bria-IMT: Novel CAR-T Therapy for Advanced Breast Cancer
BriaCell's Bria-IMT has received FDA approval as a novel CAR-T therapy, providing a promising treatment option for patients with advanced breast cancer.
CAR-T Cell Therapy Advancements and FDA Regulatory Pathways 2024
Discover the latest advancements in CAR-T cell therapy for cancer, including FDA regulatory pathways and their impact on treatment options in 2024.
FDA Approval Gene Therapies: Market Analysis Post-Hemophilia Innovations
This article delves into the impact of FDA-approved gene therapies, focusing on Hemgenix for hemophilia and the evolving market landscape.
FDA Breakthrough Therapy Designations: Advancing Alzheimer's Drug Development
Learn how FDA Breakthrough Therapy Designations are transforming Alzheimer's drug development, focusing on innovative treatments like Aducanumab.